Literature DB >> 7843816

Parvovirus B19 infection in HIV-1 infected patients with anemia.

K Gyllensten1, A Sönnerborg, C Jorup-Rönström, M Halvarsson, Z Yun.   

Abstract

Serum samples were analysed for IgM and IgG antibodies to parvovirus by ELISA and for parvovirus B19 DNA by polymerase chain reaction (PCR) in 69 HIV-1 infected Swedish patients with anemia and in 37 HIV-1 infected subjects without anemia. In 5/69 anemic patients, parvovirus B19 DNA was detected despite the lack of IgM antibody activity to the virus. The detection of parvovirus B19 DNA was significantly correlated to the degree of anemia in the anemic patients. In two patients who had a chronic anemia, a persistent parvovirus infection was detected by PCR, but not by serology, for 1 and 1.5 years, respectively. The results suggest that persistent parvovirus infection is a rare cause of anemia, but important to identify, since the infection is potentially treatable with intravenous immunoglobulin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7843816     DOI: 10.1007/bf01715548

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  29 in total

1.  Prevalence of antibodies to parvovirus B19 in selected groups of patients and healthy individuals.

Authors:  T F Schwarz; B Hottenträger; M Roggendorf
Journal:  Zentralbl Bakteriol       Date:  1992-02

2.  Electron microscopic detection of human parvovirus (B19) in a patient with HIV infection.

Authors:  I L Chrystie; J D Almeida; J Welch
Journal:  J Med Virol       Date:  1990-04       Impact factor: 2.327

3.  Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient.

Authors:  H T Weiland; M M Salimans; W E Fibbe; P M Kluin; B J Cohen
Journal:  Br J Haematol       Date:  1989-02       Impact factor: 6.998

4.  Intrauterine parvovirus infection associated with hydrops fetalis.

Authors:  T Brown; A Anand; L D Ritchie; J P Clewley; T M Reid
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

5.  Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.

Authors:  L J Anderson; C Tsou; R A Parker; T L Chorba; H Wulff; P Tattersall; P P Mortimer
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

6.  Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

Authors:  N Frickhofen; J L Abkowitz; M Safford; J M Berry; J Antunez-de-Mayolo; A Astrow; R Cohen; I Halperin; L King; D Mintzer
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

7.  Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients.

Authors:  M Musiani; A Azzi; M Zerbini; D Gibellini; S Venturoli; K Zakrzewska; M C Re; G Gentilomi; G Gallinella; M La Placa
Journal:  J Med Virol       Date:  1993-06       Impact factor: 2.327

8.  Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum.

Authors:  D D Erdman; M J Usher; C Tsou; E O Caul; G W Gary; S Kajigaya; N S Young; L J Anderson
Journal:  J Med Virol       Date:  1991-10       Impact factor: 2.327

9.  Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).

Authors:  B J Cohen; P P Mortimer; M S Pereira
Journal:  J Hyg (Lond)       Date:  1983-08

10.  Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy.

Authors:  S J Naides; E J Howard; N S Swack; C A True; J T Stapleton
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

View more
  5 in total

Review 1.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Seroprevalence of parvovirus B19 antibodies and evidence of viremia among Nigerian patients with sickle cell anemia.

Authors:  Bamidele Abiodun Iwalokun; Senapon Olusola Iwalokun; Semande Olufunmilayo Hodonu
Journal:  J Biomed Res       Date:  2013-06-15

3.  Clinical features and laboratory findings of human parvovirus B19 in human immunodeficiency virus-infected patients.

Authors:  Renata Freire Alves Pereira; Rita de Cássia Nasser Cubel Garcia; Kátia Martins Lopes de Azevedo; Sérgio Setúbal; Marilda Agudo Mendonça Teixeira de Siqueira; Solange Artimos de Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-04       Impact factor: 2.743

4.  Human parvovirus B19-associated hematopathy in HIV disease: need for clinicopathological revisit.

Authors:  Idris Abdullahi Nasir; Jessy Thomas Medugu
Journal:  J Biomed Res       Date:  2018-01-18

5.  Parvovirus B19 DNA detection in treatment-naïve HIV anemic patients in Lagos, Nigeria: a case control study.

Authors:  Oluwaseyi Sedowhe Ashaka; Olumuyiwa Babalola Salu; Ayorinde Babatunde James; Akeeb Oriowo Bola Oyefolu; AbdulAzeez Adeyemi Anjorin; Bamidele Oludare Oke; Mercy Remilekun Orenolu; Sunday Aremu Omilabu
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.